Literature DB >> 26857327

Safety of paediatric day-stay laryngeal surgery for recurrent respiratory papillomatosis.

Maayan Gruber1, Nicola Mills2, Dora Blair2, Graeme Van Der Meer2, Murali Mahadevan2.   

Abstract

OBJECTIVES: Safety assessment of day-stay laryngeal surgery in a cohort of children with recurrent respiratory papillomatosis (RRP). Recurrent respiratory papillomatosis is a chronic debilitating disease which usually requires multiple recurrent interventions under general anaesthesia. Day-stay surgery is an attractive option as it allows avoiding the inconvenience and costs of routine overnight admissions while recovering in the safe environment of the family home. This is the first study to assess the safety of day-stay laryngeal surgery in this cohort of patients.
METHODS: Retrospective cohort study of all consecutive RRP procedures performed between December 1998 and May 2015 in a single paediatric tertiary-level hospital.
RESULTS: A total of 465 surgical procedures were performed in 20 patients. Average age on diagnosis was 4.5 years. 415 (89.25%) of the procedures were done as day cases without overnight admission. Average number of procedures per patient was 20 and 25 for Children positive to HPV6 and HPV11, respectively. Only one patient after one single procedure (presenting 0.21% of total procedures, 0.24% of day-stay procedures) represented after discharge.
CONCLUSIONS: Day-stay surgery for children with RRP has a favourable safety profile in selected cases.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Laryngeal papilloma; Papillomavirus infections; Recurrent respiratory papillomatosis

Mesh:

Year:  2016        PMID: 26857327     DOI: 10.1016/j.ijporl.2016.01.004

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  1 in total

1.  Clinical features and surgical treatment for Chinese juvenile onset current respiratory papillomatosis (JORRP).

Authors:  Weixin Cui; Wen Xu; Qingwen Yang; Rong Hu
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-09-14       Impact factor: 2.503

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.